Michael Barbella, Managing Editor05.14.22
Digital health, big data, big deals, and big dollars drove ODT website traffic this past week.
Leading the pack was Arch Medical Solutions' purchase of Woburn, Mass.-based M&K Engineering. The move strengthens Arch Medical Solutions' reach of its precision medical manufacturing capabilities, as M&K has more than three decades of precision manufacturing experience serving the medical, aerospace, and defense industries. U.S. Food and Drug Administration- and ITAR-registered with an equipment list featuring multiple Swiss machines and robotic automation, M&K is a valuable addition to Arch Medical Solutions, providing vertically integrated support backed by a knowledgeable team. M&K Engineering becomes ARCH Medical & Aerospace – Woburn under the ARCH Medical Solutions umbrella.
Also peaking cybervisitors' interest was Zimmer Biomet Holdings Inc.'s debut of its new artificial intelligence (AI) capabilities within Omni Suite, an intelligent operating room (OR) designed to optimize surgical workflow and procedural efficiency by automating manual tasks and streamlining unnecessary technology and redundant hardware. The new AI feature uses cameras to automatically recognize and timestamp key OR workflow milestones, including patient entry and exit, door count, the start and stop of anesthesia, surgery and cleaning. Surgical teams are guided through a process to help optimize OR workflow based on real-time access to workflow metrics. Omni Suite’s AI feature further expands the AI capabilities of ZBEdge, a suite of integrated smart, digital and robotic technologies designed to deliver transformative data-powered clinical insights with the goal of improving patient outcomes.
Newly independent company ZimVie's first-quarter earnings report also generated interest among site viewers. The newly spun-out firm from Zimmer Biomet Holdings Inc. reported $234.7 million in sales for the quarter ended March 31, a 4.6 percent decrease (reported basis) from Q1 2021. But net loss shrunk and dental revenue grew 6.4 percent to $120.6 million. The increase in dental segment net sales was primarily driven by implant and digital dentistry net sales growth, partially offset by one less selling day in Q1 2022 versus Q1 2021.
Other items of interest included two online exclusives—one about the challenges that must still be addressed in minimally invasive surgeries, and the other about the need for orthopedic companies to transition to Industry 4.0 for better supply chain and inventory management.
Leading the pack was Arch Medical Solutions' purchase of Woburn, Mass.-based M&K Engineering. The move strengthens Arch Medical Solutions' reach of its precision medical manufacturing capabilities, as M&K has more than three decades of precision manufacturing experience serving the medical, aerospace, and defense industries. U.S. Food and Drug Administration- and ITAR-registered with an equipment list featuring multiple Swiss machines and robotic automation, M&K is a valuable addition to Arch Medical Solutions, providing vertically integrated support backed by a knowledgeable team. M&K Engineering becomes ARCH Medical & Aerospace – Woburn under the ARCH Medical Solutions umbrella.
Also peaking cybervisitors' interest was Zimmer Biomet Holdings Inc.'s debut of its new artificial intelligence (AI) capabilities within Omni Suite, an intelligent operating room (OR) designed to optimize surgical workflow and procedural efficiency by automating manual tasks and streamlining unnecessary technology and redundant hardware. The new AI feature uses cameras to automatically recognize and timestamp key OR workflow milestones, including patient entry and exit, door count, the start and stop of anesthesia, surgery and cleaning. Surgical teams are guided through a process to help optimize OR workflow based on real-time access to workflow metrics. Omni Suite’s AI feature further expands the AI capabilities of ZBEdge, a suite of integrated smart, digital and robotic technologies designed to deliver transformative data-powered clinical insights with the goal of improving patient outcomes.
Newly independent company ZimVie's first-quarter earnings report also generated interest among site viewers. The newly spun-out firm from Zimmer Biomet Holdings Inc. reported $234.7 million in sales for the quarter ended March 31, a 4.6 percent decrease (reported basis) from Q1 2021. But net loss shrunk and dental revenue grew 6.4 percent to $120.6 million. The increase in dental segment net sales was primarily driven by implant and digital dentistry net sales growth, partially offset by one less selling day in Q1 2022 versus Q1 2021.
Other items of interest included two online exclusives—one about the challenges that must still be addressed in minimally invasive surgeries, and the other about the need for orthopedic companies to transition to Industry 4.0 for better supply chain and inventory management.